fda update on tirzepatide Allows Compounded During Shortage Review FDA says tirzepatide shortage is

The medication is placed under the tongue, where it absorbs through the thin mucosal membrane directly into the bloodstream via the sublingual vein

Many patients find compounded options offer more flexible dosing and lower costs than brand alternatives

Meanwhile, GIP activation optimizes your body's insulin response and sugar processing

65 Does the paradox that either GIPR agonist or antagonist exhibits benefits in combination with GLP-1R agonist correlates with the likely reduction of internalization, following the decrement of -arrestin recruitment or the acceleration of the dissociation rate (K off ) between the ligand and receptor, owing to competition between used agonists and antagonists in endogenous GIP

Without specific details from Trustpilot, it is impossible to know the exact reason